News|Webcasts|November 7, 2023

Experiencing Bottlenecks in Your Raw Material ID?

Webinar Date/Time: Tuesday, January 9, 2024 at 11am EST | 8am PST | 4pm GMT| 5pm CET

In this webinar, the presenters will explore how complex materials can be efficiently and confidently verified using non-invasive spatially offset Raman spectroscopy (SORS). Polysorbates, solvents, and stearates will be used as case studies to demonstrate how SORS reduces risk, improves efficiency, and simplifies compliance and quality.

Register Free:
https://www.spectroscopyonline.com/spec_w/RMID

Event Overview:

While conventional handheld Raman instruments have improved raw material verification processes for many pharmaceutical drug manufacturing facilities, complex raw materials still pose significant challenges. Common complex materials—like polysorbates, solvents, and stearates—often require time-consuming and quality-compromising sampling procedures due to their remarkable spectral similarity and the challenging containers in which they’re received. Especially when received at high volumes, this prevents efficient raw material verification and can often cause bottlenecks in release to production and waste, as well as risk to raw material quality.


In this webinar, the presenters will explore how complex materials can be efficiently and confidently verified using non-invasive spatially offset Raman spectroscopy (SORS). Three common, high-volume, and complex materials (polysorbates, solvents, and stearates) will be used as case studies to demonstrate how SORS reduces risk, improves efficiency, and simplifies compliance and quality.


Key Learning Objectives:

  • Understand RMID challenges with complex raw materials.
  • Learn how SORS simplifies the verification of complex raw materials.
  • Learn the advantages of non-invasive verification for common and complex raw materials.

Who Should Attend:

  • QC lab managers, analysts, and scientists
  • PAT scientists
  • Manufacturing/warehouse managers
  • Process development managers
  • VP of quality and/or operations


Speakers:

Soleil Grise
Product Manager, Handheld Raman ID Solutions
Agilent Technologies

Soleil Grise is Product Manager for Handheld Raman Identification products at Agilent Technologies. Soleil leads the product development and commercialization of spatially offset Raman spectroscopy-based solutions, particularly for verifying raw materials at reception. She joined Agilent Technologies in 2022 and has a background in scientific instruments designed for biopharmaceutical development.


Chris Welsby
Applications Development Engineer
Agilent Technologies

Chris Welsby is an Applications Development Engineer supporting the Handheld Raman Identification Products and also the company’s Transmission Raman product for content uniformity measurement. He has quite a varied remit, including collaboration with R&D to investigate potential hardware and software enhancements, developing applications and composing application notes, providing technical support to customers, and assisting with pre-sales evaluation. Chris joined Cobalt Light Systems at the start of 2016 and transferred to Agilent Technologies when Agilent acquired Cobalt in late 2017.

Register Free: https://www.spectroscopyonline.com/spec_w/RMID


Related to this article

Spectroscopy Top 10 DOI Articles of the Month (September 2026)
The following articles are the most accessed digital object identifier (DOI) manuscripts for Spectroscopy and LCGC International during the month of September 2026. Nine articles are individually ranked here by DOI page views; the third-highest entry (186 views) was recorded against the bare journal-level DOI rather than an individual article and is therefore not attributable to a single manuscript.
Work of the surgeon in the hospital operating room. Concentrated doctor with glasses. | Image Credit: © velimir - stock.adobe.com
Jürgen Popp explains how head and neck surgeons in Jena use a Raman probe to locate tumor borders, why the technique could replace frozen section biopsies, and why optical tools must adapt to clinical workflows rather than the other way around.